Striatum Gene Expression Correlates for LM_CUE_ACTIVITY measured in BXD RI Males obtained using GeneNetwork Striatum M430V2 (Apr05) RMA. The LM_CUE_ACTIVITY measures Activity in altered context during presentation of cue under the domain Basal Behavior. The correlates were thresholded at a p-value of less than 0.001.
Authors:
Philip VM, Duvvuru S, Gomero B, Ansah TA, Blaha CD, Cook MN, Hamre KM, Lariviere WR, Matthews DB, Mittleman G, Goldowitz D, Chesler EJ
alcohol preference locus 11, male specific at D7Mit19 ((Tyr) spans 69.5-119.5 Mbp (NCBI Build 37) on Chr7. Has a preference correlation of 0.555, a LOD of 1.91 with a p < 0.003. This interval was obtained by using an interval width of 25 Mbp around the peak marker (Build 37, MGI, http://informatics.jax.org).
QTL for alcohol preference locus on Chr7 at D7Mit19 (85.32 Mbp , Build 37)
Description:
alcohol preference locus spans 60.32 - 110.32 Mbp (NCBI Build 37) on Chr7. This interval was obtained by using an interval width of 25 Mbp around the peak marker (Build 37, MGI, http://informatics.jax.org).
QTL for nicotine sensitivity on Chr7 at D7Mit66 (116.91 Mbp , Build 37)
Description:
nicotine sensitivity spans 91.91 - 141.91 Mbp (NCBI Build 37) on Chr7. This interval was obtained by using an interval width of 25 Mbp around the peak marker (Build 37, MGI, http://informatics.jax.org).
None - Basal gene expression profiles between C57BL/6J, DBA/2J, 129P3/J, and SWR/J strains DNA microarray Change in gene expression Two-way analysis of variance (ANOVA). 3,457 probe sets (corresponded to 2,870 different transcripts) with significant inter-strain differences (differ by at least 1.2-fold) - False discovery rate [FDR] < 1%, , rank > 3. Such a large disparity in the mouse striatal transcriptome was estimated by comparing nine array replicates prepared per strain from all of the treatment groups. More than half of the identified probe sets exhibited markedly significant results (1,735 with rank > 7). (NIF Method ID 84.1)
Authors:
Korostynski M, Piechota M, Kaminska D, Solecki W, Przewlocki R
Ethanol Induced Hypothermia Chr# 7 rs13479153(25722935) with right flanking marker rs3700068(4187548) and left marker rs3716088(140189839). This was mapped in 300 + (b6x129)F2 mice.
Rotarod Baseline Chr# 7 rs4226783(100081465) with right flanking marker rs8260975(53682778) and left marker rs13479506 (131822778). This was mapped in 300 + (b6x129)F2 mice.
Average rotarod training latency Chr# 7 mCV23423763(68111945) with right flanking marker rs3700068(4187548) and left marker rs3663988(146505067). This was mapped in 300 + (b6x129)F2 mice.
QTL associated with anti-erythrocyte autoantibody modifier 2. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (88630562)
Authors:
Santiago-Raber ML, Haraldsson MK, Theofilopoulos AN, Kono DH
QTL associated with collagen induced arthritis 41. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (81093848)
QTL associated with experimental allergic encephalomyelitis susceptibility 26. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (122709201)
Authors:
Jirholt J, Lindqvist AK, Karlsson J, Andersson A, Holmdahl R
QTL associated with experimental allergic encephalomyelitis susceptibility 4. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (108349641)
Authors:
Teuscher C, Doerge RW, Fillmore PD, Blankenhorn EP
QTL associated with "early growth rate, maternal effect 3". This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (81821259)
QTL associated with hepatocarcinogenesis susceptibility 1. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (81821259)
Authors:
Gariboldi M, Manenti G, Canzian F, Falvella FS, Pierotti MA, Della Porta G, Binelli G, Dragani TA
QTL associated with wound healing/regeneration 6. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (111543239)
Authors:
Heber-Katz E, Leferovich JM, Bedelbaeva K, Gourevitch D
GeneWeaver